Association of APOE genotype and CSF Aβ and tau biomarkers with cognitive and motor phenotype in ALS

被引:0
|
作者
Maranzano, A. [1 ]
Verde, F. [3 ]
Dubini, A. [1 ]
Torre, S. [1 ]
Colombo, E. [1 ]
Doretti, A. [1 ]
Gentile, F. [2 ]
Manini, A. [2 ]
Milone, I. [1 ]
Brusati, A. [4 ]
Peverelli, S. [1 ]
Santangelo, S. [5 ]
Torresani, E. [1 ]
Gentilini, D. [6 ]
Messina, S. [1 ]
Morelli, C. [1 ]
Poletti, B. [1 ]
Ratti, A.
Silani, V. [3 ]
Ticozzi, N. [1 ,3 ]
机构
[1] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy
[2] Univ Milan, Neurol Residency Program, Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Dino Ferrari Ctr, Milan, Italy
[4] Univ Pavia, Dipartimento Sci Sistema Nervoso Comportamento, Pavia, Italy
[5] Univ Milan, Dept Med Biotechnol & Mol Med, Milan, Italy
[6] Ist Auxol Italiano IRCCS, Bioinformat & Stat Genom Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-113
引用
收藏
页码:194 / 195
页数:2
相关论文
共 50 条
  • [41] Early tau pathology in young Japanese forensic autopsy series: Frequency and association with APOE genotype and suicidal risk
    Yoshida, Koji
    Hata, Yukiko
    Terasawa, Hideo
    Shimizu, Hirotaka
    Uehara, Toshiyuki
    Nakatsuji, Yuji
    Kita, Yasushi
    Nishida, Naoki
    BRAIN PATHOLOGY, 2019, 29 : 71 - 71
  • [42] Association of CAG repeat length in HTT gene with CSF tau in subjective cognitive decline and mild cognitive impairment
    Mazzeo, S.
    Bessi, V.
    Bagnoli, S.
    Giacomucci, G.
    Ferrari, C.
    Padiglioni, S.
    Balestrini, J.
    Franchi, V.
    Ingannato, A.
    Conti, V.
    Sorbi, S.
    Nacmias, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 563 - 563
  • [43] Effect of ApoE4 Genotype on the Association Between Metabolic Phenotype and Subclinical Atherosclerosis in Postmenopausal Women
    Sriprasert, Intira
    Mack, Wendy Jean
    Hodis, Howard Neil
    Allayee, Hooman
    Brinton, Roberta Diaz
    Karim, Roksana
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (07): : 1031 - 1037
  • [44] No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
    Korthauer, Laura E.
    Giugliano, Robert P.
    Guo, Jianping
    Sabatine, Marc S.
    Sever, Peter
    Keech, Anthony
    Atar, Dan
    Kurtz, Christopher
    Ruff, Christian T.
    Mach, Francois
    Ott, Brian R.
    PLOS ONE, 2022, 17 (04):
  • [45] Tau-related reduction of glucose metabolism in mild cognitive impairment occurs independently of APOE ε4 genotype and is influenced by Aβ
    Carbonell, Felix
    Mcnicoll, Carolann
    Zijdenbos, Alex P.
    Bedell, Barry J.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [46] Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences
    Xu, Chun
    Xiao, Danqing
    Su, Brenda Bin
    Saveron, Jaime Miguel
    Gamez, Daniela
    Navia, R. Osvaldo
    Wang, Nianyang
    Roy, Upal
    Adjeroh, Donald A.
    Wang, Kesheng
    NEUROLOGICAL SCIENCES, 2024, 45 (03) : 1041 - 1050
  • [47] Cognitive Performance in Young APOE ε4 Carriers: A Latent Variable Approach for Assessing the Genotype-Phenotype Relationship
    Li, Xiaojing
    Hildebrandt, Andrea
    Sommer, Werner
    Wilhelm, Oliver
    Reuter, Martin
    Montag, Christian
    Zhou, Changsong
    BEHAVIOR GENETICS, 2019, 49 (05) : 455 - 468
  • [48] Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer’s disease: racial differences
    Chun Xu
    Danqing Xiao
    Brenda Bin Su
    Jaime Miguel Saveron
    Daniela Gamez
    R. Osvaldo Navia
    Nianyang Wang
    Upal Roy
    Donald A. Adjeroh
    Kesheng Wang
    Neurological Sciences, 2024, 45 : 1041 - 1050
  • [49] Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype
    L'Heureux, Joanna E.
    Corbett, Anne
    Ballard, Clive
    Vauzour, David
    Creese, Byron
    Winyard, Paul G.
    Jones, Andrew M.
    Vanhatalo, Anni
    PNAS NEXUS, 2025, 4 (01):
  • [50] Association of CSF total tau and phospho-tau (181) with cerebral atrophy in mild cognitive impairment and Alzheimer's disease
    Thomann, P. A.
    Kaiser, E.
    P, Schoenknecht
    Pantel, J.
    Essig, M.
    Schroeder, J.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 243 - 243